# A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

> **NCT01388933** · PHASE2 · TERMINATED · sponsor: **Tsumura USA** · enrollment: 79 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** TU-100
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT01388933
- **Lead sponsor:** Tsumura USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 79 (ACTUAL)
- **Why stopped:** Study stopped due to low enrollment
- **Last updated:** 2015-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01388933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01388933, "A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01388933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*